Concepedia
Statistics
Publications
11
Citations
509
H-Index
Active since
2008
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United States)
Novartis (United States)
Novartis (Switzerland)
University of Copenhagen
Nalina Dronamraju is an author at AstraZeneca (Sweden).
Publications per year
2008–2020
Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
Robert A. Hauser, Michel Panisset, Giovanni Abbruzzese et al. · Movement Disorders · 2008 · 117 citations
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes
Dirk Müller‐Wieland, Monika Kellerer, Katarzyna Cypryk et al. · Diabetes Obesity and Metabolism · 2018 · 72 citations · Full text
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial
Austin G. Stack, Nalina Dronamraju, Joanna Parkinson et al. · American Journal of Kidney Diseases · 2020 · 68 citations · Full text
Mavoglurant in Parkinson's patients with <scp>l</scp> ‐Dopa‐induced dyskinesias: Two randomized phase 2 studies
Claudia Trenkwalder, Fabrizio Stocchi, Werner Poewe et al. · Movement Disorders · 2016 · 66 citations
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients
Rajeev Kumar, Robert A. Hauser, Joseph Mostillo et al. · International Journal of Neuroscience · 2013 · 52 citations
1–5 of 11